| 328.79 BATS BZX Real-Time Price As of 1:36pm ET |  -9.44 / -2.79%Today’s Change | 249.17 Today|||52-Week Range 388.67 | +3.21% Year-to-Date |
| Previous close | 338.23 |
| Today’s open | 337.12 |
| Day’s range | 327.98 - 337.12 |
| Volume | 30,051 |
| Average volume (3 months) | 1,546,332 |
| Market cap | $68.1B |
| Earnings growth (last year) | -29.56% |
| Earnings growth (this year) | +15.95% |
| Earnings growth (next 5 years) | +7.20% |
| Revenue growth (last year) | +7.81% |
| P/E ratio | 23.3 |
| Price/Sales | 6.17 |
| Price/Book | 5.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -9.33 | -2.84% |
| GILDGilead Sciences | -2.06 | -2.72% |
| TLRYTilray Inc | +0.94 | +0.63% |
| NBIXNeurocrine Bioscienc... | -1.24 | -1.08% |
| Next reporting date | October 23, 2018 |
| EPS forecast (this quarter) | $6.77 |
| Annual revenue (last year) | $11.0B |
| Annual profit (last year) | $2.5B |
| Net profit margin | 23.10% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michel Vounatsos |
Chief Financial Officer & Executive Vice President Jeffrey D. Capello |
Corporate headquarters Cambridge, Massachusetts |
